BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1665959)

  • 1. Potentiating effect of ribavirin on the anti-herpes activity of acyclovir.
    Pancheva SN
    Antiviral Res; 1991 Sep; 16(2):151-61. PubMed ID: 1665959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The synergistic antiviral effect of acyclovir and ribavirin against the herpes simplex type-1 virus and the pseudorabies virus in vitro].
    Shishkov S; Pancheva S
    Acta Microbiol Bulg; 1990; 25():69-75. PubMed ID: 2166426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined acyclovir and ribavirin on experimental herpes simplex virus type 1 keratoconjunctivitis in rabbits.
    Pancheva S; Shishkov S; Ilieva D
    Acta Microbiol Bulg; 1993; 29():61-4. PubMed ID: 8390133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil in a rabbit model of herpetic keratitis.
    Trousdale MD; Law JL; Yarber FA; Watanabe KA; Fox JJ
    Antiviral Res; 1992 Feb; 17(2):157-67. PubMed ID: 1313221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
    Taylor JL; Casey MS; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
    Anand B; Nashed Y; Mitra A
    Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of flavonoids and acyclovir against herpesviruses in cell cultures.
    Mucsi I; Gyulai Z; Béládi I
    Acta Microbiol Hung; 1992; 39(2):137-47. PubMed ID: 1339152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
    Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
    Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.
    Park PJ; Antoine TE; Farooq AV; Valyi-Nagy T; Shukla D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6373-81. PubMed ID: 23989188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies of 9-(1, 3-dihydroxy-2-propoxymethyl)-guanine(DHPG) against herpes simplex virus].
    Chen ZJ; Liu WG; Song JZ
    Yao Xue Xue Bao; 1989; 24(5):331-4. PubMed ID: 2481939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
    van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
    Naito T; Shiota H; Nitta K; Mimura Y
    Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro sensitivity to antiviral agents of herpes simplex viruses isolated from patients with herpetic keratitis].
    Mori Y; Inoue Y; Shimomura Y; Manabe R
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):484-7. PubMed ID: 2171305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined antiviral effects of flavonoids and 5-ethyl-2'-deoxyuridine on the multiplication of herpesviruses.
    Mucsi I
    Acta Virol; 1984 Sep; 28(5):395-400. PubMed ID: 6151353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.